103 related articles for article (PubMed ID: 19762243)
21. Comparative in silico-in vivo evaluation of ASGP-R ligands for hepatic targeting of curcumin Gantrez nanoparticles.
D'Souza AA; Jain P; Galdhar CN; Samad A; Degani MS; Devarajan PV
AAPS J; 2013 Jul; 15(3):696-706. PubMed ID: 23580183
[TBL] [Abstract][Full Text] [Related]
22. An artificial receptor for glycoproteins.
Gupta G; Lowe CR
J Mol Recognit; 2004; 17(3):218-35. PubMed ID: 15137032
[TBL] [Abstract][Full Text] [Related]
23. Low asialoglycoprotein receptor expression as markers for highly proliferative potential hepatocytes.
Ise H; Sugihara N; Negishi N; Nikaido T; Akaike T
Biochem Biophys Res Commun; 2001 Jul; 285(2):172-82. PubMed ID: 11444822
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting.
Bernardes GJ; Kikkeri R; Maglinao M; Laurino P; Collot M; Hong SY; Lepenies B; Seeberger PH
Org Biomol Chem; 2010 Nov; 8(21):4987-96. PubMed ID: 20820666
[TBL] [Abstract][Full Text] [Related]
25. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor.
De Luca S; Saviano M; Della Moglie R; Digilio G; Bracco C; Aloj L; Tarallo L; Pedone C; Morelli G
ChemMedChem; 2006 Sep; 1(9):997-1006. PubMed ID: 16915602
[TBL] [Abstract][Full Text] [Related]
26. A specific antibody to the carbohydrate recognition domain of the asialoglycoprotein receptor RHL1 subunit does not react with RHL2/3 but blocks ligand binding.
Zeng FY; Oka JA; Weigel PH
Biochem Biophys Res Commun; 1998 Aug; 249(1):236-40. PubMed ID: 9705864
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding.
Rodriguez AL; Tamrazi A; Collins ML; Katzenellenbogen JA
J Med Chem; 2004 Jan; 47(3):600-11. PubMed ID: 14736241
[TBL] [Abstract][Full Text] [Related]
28. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
[TBL] [Abstract][Full Text] [Related]
29. Identification of the domain in the human interleukin-11 receptor that mediates ligand binding.
Schleinkofer K; Dingley A; Tacken I; Federwisch M; Müller-Newen G; Heinrich PC; Vusio P; Jacques Y; Grötzinger J
J Mol Biol; 2001 Feb; 306(2):263-74. PubMed ID: 11237599
[TBL] [Abstract][Full Text] [Related]
30. Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetry.
Crump MP; Ceska TA; Spyracopoulos L; Henry A; Archibald SC; Alexander R; Taylor RJ; Findlow SC; O'Connell J; Robinson MK; Shock A
Biochemistry; 2004 Mar; 43(9):2394-404. PubMed ID: 14992576
[TBL] [Abstract][Full Text] [Related]
31. Glycomimetic ligands for the human asialoglycoprotein receptor.
Mamidyala SK; Dutta S; Chrunyk BA; Préville C; Wang H; Withka JM; McColl A; Subashi TA; Hawrylik SJ; Griffor MC; Kim S; Pfefferkorn JA; Price DA; Menhaji-Klotz E; Mascitti V; Finn MG
J Am Chem Soc; 2012 Feb; 134(4):1978-81. PubMed ID: 22280495
[TBL] [Abstract][Full Text] [Related]
32. Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and in vitro evaluation.
Paranjpe PV; Chen Y; Kholodovych V; Welsh W; Stein S; Sinko PJ
J Control Release; 2004 Nov; 100(2):275-92. PubMed ID: 15544875
[TBL] [Abstract][Full Text] [Related]
33. Targeting norovirus infection-multivalent entry inhibitor design based on NMR experiments.
Rademacher C; Guiard J; Kitov PI; Fiege B; Dalton KP; Parra F; Bundle DR; Peters T
Chemistry; 2011 Jun; 17(27):7442-53. PubMed ID: 21567493
[TBL] [Abstract][Full Text] [Related]
34. A new N-acetylgalactosamine containing peptide as a targeting vehicle for mammalian hepatocytes via asialoglycoprotein receptor endocytosis.
Wu YT; Jiaang WT; Lin KG; Huang CM; Chang CH; Sun YL; Fan KH; Hsu WC; Wang HE; Lin SB; Chen ST
Curr Drug Deliv; 2004 Apr; 1(2):119-27. PubMed ID: 16305377
[TBL] [Abstract][Full Text] [Related]
35. N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.
Rivara S; Lodola A; Mor M; Bedini A; Spadoni G; Lucini V; Pannacci M; Fraschini F; Scaglione F; Sanchez RO; Gobbi G; Tarzia G
J Med Chem; 2007 Dec; 50(26):6618-26. PubMed ID: 18052314
[TBL] [Abstract][Full Text] [Related]
36. Effects of hepatitis B virus S protein on human sperm function.
Zhou XL; Sun PN; Huang TH; Xie QD; Kang XJ; Liu LM
Hum Reprod; 2009 Jul; 24(7):1575-83. PubMed ID: 19279032
[TBL] [Abstract][Full Text] [Related]
37. Rational design and synthesis of androgen receptor-targeted nonsteroidal anti-androgen ligands for the tumor-specific delivery of a doxorubicin-formaldehyde conjugate.
Cogan PS; Koch TH
J Med Chem; 2003 Nov; 46(24):5258-70. PubMed ID: 14613328
[TBL] [Abstract][Full Text] [Related]
38. Rational optimization of the binding affinity of CD4 targeting peptidomimetics with potential anti HIV activity.
Neffe AT; Bilang M; Grüneberg I; Meyer B
J Med Chem; 2007 Jul; 50(15):3482-8. PubMed ID: 17602545
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of novel doxorubicin-containing ASGP-R-targeted drug-conjugates.
Ivanenkov YA; Majouga AG; Petrov RA; Petrov SA; Kovalev SV; Maklakova SY; Yamansarov EY; Saltykova IV; Deyneka EV; Filkov GI; Kotelianski VE; Zatsepin TS; Beloglazkina EK
Bioorg Med Chem Lett; 2018 Feb; 28(3):503-508. PubMed ID: 29254645
[TBL] [Abstract][Full Text] [Related]
40. The effect of ethanol on asialoglycoprotein receptor-mediated phagocytosis of apoptotic cells by rat hepatocytes.
McVicker BL; Tuma DJ; Kubik JA; Hindemith AM; Baldwin CR; Casey CA
Hepatology; 2002 Dec; 36(6):1478-87. PubMed ID: 12447874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
